Now, to further characterize the miRNA expression profile of breast tumors, we have compared each subtype with the healthy breast tissues and identified 335, 98, 157 and 249 differentially expressed (FDR<0.05) miRNAs in triple negative, Her2, luminal B and luminal A tumors, respectively. This evidence concerns the gene ERBB2 and breast neoplasm.